Natural killer cells and metastases from pharyngeal carcinoma.

[1]  W. Hong,et al.  Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients. , 1988, Cancer research.

[2]  A. Lichtenstein,et al.  Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. , 1988, Cancer research.

[3]  S. Pathak,et al.  Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. , 1988, Cancer research.

[4]  R. Fisher,et al.  In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. , 1988, Journal of immunology.

[5]  L. Lanier,et al.  In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. M. Linehan,et al.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.

[7]  B. Pedersen,et al.  Inhibition of Natural Killer Cell Activity by Antigen‐Antibody Complexes , 1986, Allergy.

[8]  B. Campbell,et al.  Pharyngeal carcinoma and natural killer cell activity. , 1986, American journal of surgery.

[9]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[10]  Z. Grossman,et al.  Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation. , 1986, Cancer research.

[11]  G. Malaponte,et al.  Circulating immunocomplexes and laryngeal carcinoma. , 1985, Archives of otolaryngology.

[12]  C. Balch,et al.  Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. , 1985, Journal of immunology.

[13]  M. Olson,et al.  C1q binding and C1 activation by various isolated cellular membranes. , 1983, Journal of immunology.

[14]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[15]  J. Karsh,et al.  Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. , 1981, Clinical immunology and immunopathology.

[16]  R. Veltri,et al.  Soluble Immune Complexes in Sera from Head and Neck Cancer Patients: A Preliminary Report , 1978, Otolaryngology.